745511
Last Update Posted: 2009-06-09
Recruiting status is unknown
All Genders accepted | 50 Years + |
96 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Pilot Study to Evaluate the Safety and Efficacy of Treatment With ORA102 Combined With Avastin (Bevacizumab) Versus Avastin Alone, in Patients With Neovascular Age Related Macular Degeneration (AMD)
This is s randomized, multi-center, double blind, 3 arm, phase I/II pilot study to evaluate the safety and efficacy of treatment with ORA102 combined with Avastin (Bevacizumab) versus Avastin alone, in patients with neo-vascular age related macular degeneration (AMD).
Eligibility
Relevant conditions:
Macular Degeneration
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Contact Information
Overall Contact
Yossi Israeli
yos@orabio.com
+972-26067006
Data sourced from ClinicalTrials.gov